These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1793890)
21. Effects of sofalcone on necrotizing agents-induced gastric lesions and on endogenous prostaglandins in rats stomachs. Saziki R; Arai I; Isobe Y; Hirose H; Aihara H J Pharmacobiodyn; 1984 Nov; 7(11):791-7. PubMed ID: 6597872 [TBL] [Abstract][Full Text] [Related]
22. Protection against alcohol-induced gastric mucosal injury by geranylgeranylacetone: effect of indomethacin. Bilski J; Murty VL; Nadziejko C; Sarosiek J; Aono M; Moriga M; Slomiany A; Slomiany BL Digestion; 1988; 41(1):22-33. PubMed ID: 3203824 [TBL] [Abstract][Full Text] [Related]
23. Effect of sofalcone on the gastric cell proliferation in the experimental gastritis of rats. Kohno Y; Tanikawa K; Ohta K; Suwa T Jpn J Pharmacol; 1987 Apr; 43(4):407-13. PubMed ID: 3613287 [TBL] [Abstract][Full Text] [Related]
24. Cytoprotective effect of sofalcone in the rat gastric mucosa. Isobe Y; Hirose H; Muramatsu M; Aihara H Arzneimittelforschung; 1985; 35(1):138-41. PubMed ID: 3857044 [TBL] [Abstract][Full Text] [Related]
25. Protection of gastric surface epithelial cells of rats by 16,16-dimethyl prostaglandin E2 and sofalcone, a synthetic flavonoid derivative of sophoradin, against ethanol. Arakawa T; Nakamura A; Yamada H; Nebiki H; Satoh H; Fukuda T; Kobayashi K Digestion; 1988; 41(2):61-7. PubMed ID: 3220178 [TBL] [Abstract][Full Text] [Related]
27. Effect of sofalcone on localization of 15-hydroxyprostaglandin dehydrogenase, an enzyme that metabolizes prostaglandin E2, in rat gastric mucosa: an immunohistochemical study. Kobayashi K; Higuchi K; Arakawa T; Matsumoto T; Nagura H J Clin Gastroenterol; 1992; 14 Suppl 1():S39-42. PubMed ID: 1629577 [TBL] [Abstract][Full Text] [Related]
28. Effect of 2'-carboxymethoxy-4,4'-bis(3-methyl-2-butenyloxy) chalcone (sofalcone) on chronic gastric ulcers in rats. Kimura M; Saziki R; Arai I; Tarumoto Y; Nakane S Jpn J Pharmacol; 1984 Aug; 35(4):389-96. PubMed ID: 6209441 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of gastric H+,K(+)-ATPase by the anti-ulcer agent, sofalcone. Murakami S; Muramatsu M; Aihara H; Otomo S Biochem Pharmacol; 1991 Sep; 42(7):1447-51. PubMed ID: 1656986 [TBL] [Abstract][Full Text] [Related]
30. Effect of sofalcone on acute gastric mucosal lesions induced by aspirin and ethanol in reference to the biosynthesis of gastric mucosal glycoprotein. Muramatsu M; Murakami S; Arai I; Isobe Y; Hirose H; Usuki C; Aihara H Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):321-37. PubMed ID: 3797811 [TBL] [Abstract][Full Text] [Related]
31. Gastroprotective properties of ebrotidine. A review. Slomiany BL; Piotrowski J; Slomiany A Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744 [TBL] [Abstract][Full Text] [Related]
32. Antiulcer drugs and gastric prostaglandin E2: an in vitro study. Ota S; Takahashi M; Yoshiura K; Hata Y; Kawabe T; Terano A; Omata M J Clin Gastroenterol; 1993; 17 Suppl 1():S15-21. PubMed ID: 7904284 [TBL] [Abstract][Full Text] [Related]
33. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication. Slomiany BL; Piotrowski J; Slomiany A; Konturek JW; Domschke WW Gen Pharmacol; 1998 Aug; 31(2):227-31. PubMed ID: 9688464 [TBL] [Abstract][Full Text] [Related]
34. Enzymatic sulfation of gastric mucous glycoprotein in rat--changes in glycoprotein sulfotransferase activity with stress and anti-ulcer agent, sofalcone. Murakami S; Muramatsu M; Aihara H; Honda A; Mori Y Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):77-98. PubMed ID: 3478774 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic effects of sofalcone on experimental gastritis. Kishimoto S; Okamoto K; Kambara A; Kajiyama G; Miyoshi A; Suwa T Arzneimittelforschung; 1987 Aug; 37(8):944-7. PubMed ID: 3675690 [TBL] [Abstract][Full Text] [Related]
36. Effect of sofalcone on gastric mucosal injury induced by ischemia-reperfusion and its antioxidant properties. Yoshikawa T; Nakamura S; Takahashi S; Naito Y; Kondo M J Clin Gastroenterol; 1993; 17 Suppl 1():S111-5. PubMed ID: 8283005 [TBL] [Abstract][Full Text] [Related]
37. Sofalcone, a gastric mucosa protective agent, increases vascular endothelial growth factor via the Nrf2-heme-oxygenase-1 dependent pathway in gastric epithelial cells. Shibuya A; Onda K; Kawahara H; Uchiyama Y; Nakayama H; Omi T; Nagaoka M; Matsui H; Hirano T Biochem Biophys Res Commun; 2010 Jul; 398(3):581-4. PubMed ID: 20599750 [TBL] [Abstract][Full Text] [Related]
38. [The effect of sofalcone on the kinetics of the generative cells and superficial epithelial cells in mouse gastric mucosa]. Magami Y; Azuma T; Sasaki Z; Inokuchi H; Kawai K Nihon Yakurigaku Zasshi; 1989 Dec; 94(6):363-9. PubMed ID: 2606377 [TBL] [Abstract][Full Text] [Related]
39. Further study of mucosal repair by sofalcone in experimental gastritis. Kishimoto S; Kobuke K; Kobayashi H; Kajiyama G; Miyoshi A; Kohno Y; Tanikawa K; Ohta K; Suwa T J Clin Gastroenterol; 1990; 12 Suppl 1():S181-6. PubMed ID: 2212544 [TBL] [Abstract][Full Text] [Related]
40. Effect of sofalcone on the expression of hepatocyte growth factor (HGF) and a brief review of HGF in the stomach. Takahashi M; Hata Y; Terano A J Clin Gastroenterol; 1997; 25 Suppl 1():S21-7. PubMed ID: 9479623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]